Although p53 was upregulated in the hep-c-MYC liver cancer samples (Fig. 4C), the AR-V7 co-expression did not significantly affect the p53 expression level (Fig. 4C), suggesting that AR-V7 might directly suppress the Cldn7 expression downstream of p53. The gene discussed is CLDN7; the disease is liver cancer.